Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | March 01, 2024 09:09am

Gainers

  • Adial Pharmaceuticals (NASDAQ:ADIL) shares rose 76.0% to $3.59 during Friday's pre-market session. The company's market cap stands at $5.9 million.
  • BioVie (NASDAQ:BIVI) shares moved upwards by 75.8% to $2.18. The company's market cap stands at $86.9 million.
  • Bone Biologics (NASDAQ:BBLG) shares rose 28.97% to $3.16. The market value of their outstanding shares is at $1.6 million.
  • Y-mAbs Therapeutics (NASDAQ:YMAB) stock moved upwards by 21.49% to $20.29. The company's market cap stands at $885.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Cardiff Oncology (NASDAQ:CRDF) shares increased by 18.41% to $2.09. The company's market cap stands at $93.3 million. The company's, Q4 earnings came out yesterday.
  • Biodesix (NASDAQ:BDSX) stock rose 17.53% to $1.81. The market value of their outstanding shares is at $163.7 million. As per the news, the Q4 earnings report came out today.

Losers

  • Scilex Holding (NASDAQ:SCLX) shares declined by 35.7% to $1.46 during Friday's pre-market session. The company's market cap stands at $230.5 million.
  • Humacyte (NASDAQ:HUMA) shares declined by 25.52% to $3.24. The market value of their outstanding shares is at $335.5 million.
  • Gritstone Bio (NASDAQ:GRTS) stock declined by 21.08% to $2.21. The company's market cap stands at $210.7 million.
  • Precision BioSciences (NASDAQ:DTIL) shares fell 20.55% to $14.7. The company's market cap stands at $59.7 million.
  • Vivani Medical (NASDAQ:VANI) shares decreased by 19.92% to $3.38. The company's market cap stands at $172.4 million.
  • DermTech (NASDAQ:DMTK) stock fell 16.41% to $1.07. The market value of their outstanding shares is at $36.6 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADIL BBLG BDSX BIVI CRDF DMTK DTIL GRTS HUMA SCLX VANI YMAB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist